Found: 17
Select item for more details and to access through your institution.
Treatment with low‐dose, single‐agent belantamab mafodotin is safe and provides long‐term responses in heavily pretreated multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 367, doi. 10.1111/ejh.14120
- By:
- Publication type:
- Article
Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 45, doi. 10.1111/bjh.18479
- By:
- Publication type:
- Article
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 186, doi. 10.1111/bjh.17608
- By:
- Publication type:
- Article
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211035272
- By:
- Publication type:
- Article
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Bortezomib washout duration prior to stem cell mobilization in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 30, doi. 10.1111/ejh.13404
- By:
- Publication type:
- Article
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment Patterns and Clinical Outcomes Across Consecutive Treatment Lines in Multiple Myeloma Patients: Single-Center Real World Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e251, doi. 10.1016/j.clml.2019.09.416
- By:
- Publication type:
- Article
Outcomes of Post-Induction Bortezomib Therapy in Patients with Newly diagnosed Multiple Myeloma: A Multi-Center Retrospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e296, doi. 10.1016/j.clml.2019.09.486
- By:
- Publication type:
- Article
Treatment patterns and clinical outcomes in high‐risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi‐center retrospective study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 810, doi. 10.1002/ajh.25098
- By:
- Publication type:
- Article
Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Slow Lymphocyte Reconstitution After Autologous Stem Cell Transplantation is Associated with Increased Apoptosis Rate of CD8 Cells and Predicts Adverse Clinical Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S388, doi. 10.1016/j.clml.2017.07.240
- By:
- Publication type:
- Article
Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 2, p. 136, doi. 10.1111/ejh.12558
- By:
- Publication type:
- Article
Bone Marrow-Related Syncope.
- Published in:
- Israel Medical Association Journal, 2015, v. 17, n. 10, p. 653
- By:
- Publication type:
- Article
JAK2 Mutation: An Aid in the Diagnosis of Occult Myeloproliferative Neoplasms in Patients with Major Intraabdominal Vein Thrombosis and Normal Blood Counts.
- Published in:
- Israel Medical Association Journal, 2013, v. 15, n. 11, p. 698
- By:
- Publication type:
- Article